Loading...
XSHG603883
Market cap1.63bUSD
Jan 09, Last price  
15.68CNY
1D
-0.25%
1Q
-2.36%
Jan 2017
-38.59%
IPO
10.22%
Name

LBX Pharmacy Chain JSC

Chart & Performance

D1W1MN
XSHG:603883 chart
P/E
12.79
P/S
0.53
EPS
1.23
Div Yield, %
3.15%
Shrs. gr., 5y
7.98%
Rev. gr., 5y
18.83%
Revenues
22.44b
+11.21%
2,467,038,1172,841,634,8833,321,294,6443,942,877,2954,568,482,8616,094,431,2757,501,432,3269,471,089,28811,663,176,22913,966,699,24015,695,664,14720,175,519,30322,437,489,012
Net income
929m
+18.35%
98,963,320125,036,547160,720,726202,382,081240,501,810296,895,435370,800,158435,036,736508,711,909621,090,283669,236,722784,961,520929,023,131
CFO
2.73b
+17.95%
0148,854,663136,517,629247,144,683257,149,257313,257,834492,131,548913,025,5571,032,537,1771,447,477,8502,298,296,5442,314,315,0092,729,838,947
Dividend
Oct 10, 20240.3307 CNY/sh
Earnings
Jun 13, 2025

Profile

LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company operates stores in 21 provincial markets, including Hunan, Jiangsu, Gansu, Shaanxi, Guangxi, Anhui, Zhejiang, Inner Mongolia, Hubei, Tianjin, Henan, Shanghai, Shandong, Guangdong, Hebei, Beijing, Jiangxi, Ningxia, Sichuan, Fujian, and Guizhou. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.
URL
https://www.lbxdrugs.com/
IPO date
Apr 23, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
22,437,489
11.21%
20,175,519
28.54%
Cost of revenue
20,074,330
17,879,939
Unusual Expense (Income)
NOPBT
2,363,159
2,295,580
NOPBT Margin
10.53%
11.38%
Operating Taxes
284,274
231,375
Tax Rate
12.03%
10.08%
NOPAT
2,078,885
2,064,206
Net income
929,023
18.35%
784,962
17.29%
Dividends
(374,707)
(223,979)
Dividend yield
1.65%
0.96%
Proceeds from repurchase of equity
(5,976)
BB yield
0.03%
Debt
Debt current
2,283,265
2,056,345
Long-term debt
4,121,080
5,220,690
Deferred revenue
19,098
Other long-term liabilities
37,148
Net debt
3,907,022
4,395,809
Cash flow
Cash from operating activities
2,729,839
2,314,315
CAPEX
(620,866)
(308,438)
Cash from investing activities
(761,264)
(1,456,649)
Cash from financing activities
(2,427,829)
(142,621)
FCF
2,111,995
2,561,777
Balance
Cash
1,976,485
2,413,922
Long term investments
520,838
467,303
Excess cash
1,375,448
1,872,450
Stockholders' equity
4,859,844
4,248,664
Invested Capital
10,983,724
10,502,319
ROIC
19.35%
20.71%
ROCE
19.12%
18.50%
EV
Common stock shares outstanding
759,579
577,178
Price
29.90
-26.12%
40.47
6.56%
Market cap
22,711,402
-2.77%
23,358,377
15.93%
EV
29,613,112
28,761,761
EBITDA
3,828,636
3,481,200
EV/EBITDA
7.73
8.26
Interest
185,604
232,135
Interest/NOPBT
7.85%
10.11%